Molina Healthcare (NYSE:MOH) Cut to Hold at Wells Fargo & Company
Molina Healthcare (NYSE:MOH) was downgraded by Wells Fargo & Company from a "strong-buy" to a "hold" rating. This follows several other analysts' reports, resulting in a consensus "Hold" rating and an average price target of $157.86 for the stock. The company recently reported mixed quarterly earnings, missing EPS estimates but exceeding revenue expectations, and experienced an insider stock sale by a director.
SAIC launches alliance to accelerate state-led execution of $50B rural health care transformation program
Science Applications International Corp. (SAIC) has formed the Alliance for Advancing Rural Healthcare (AARH) to help state governments implement the federal Rural Health Transformation Program, a $50 billion initiative. The alliance, which includes Walgreens, Arcadia, and other healthcare organizations, aims to strengthen rural healthcare systems by improving access to care, modernizing infrastructure, and expanding workforce capacity. AARH will work with states to translate strategy into tangible, sustainable improvements for rural communities across the U.S.
Skandinaviska Enskilda Banken AB publ Sells 4,649 Shares of Labcorp Holdings Inc. $LH
Skandinaviska Enskilda Banken AB publ reduced its stake in Labcorp Holdings Inc. by 17.2%, selling 4,649 shares and retaining 22,458 shares worth $6.45 million. Despite this, other institutions significantly increased their holdings, with 95.94% of Labcorp stock owned by institutional investors. Labcorp reported strong financial results, beating EPS expectations, providing positive FY 2026 guidance, and declaring a quarterly dividend, though recent insider sales by the CEO and EVP were noted.
Persistent Asset Partners Ltd Takes $8.19 Million Position in Centene Corporation $CNC
Persistent Asset Partners Ltd recently acquired a new position in Centene Corporation (NYSE:CNC), purchasing 229,544 shares valued at approximately $8.19 million, making it their largest holding. Other institutional investors also increased their stakes in Centene during the third quarter. The company reported earnings of ($1.19) EPS on revenues of $49.73 billion for the latest quarter, surpassing analyst estimates.
Molina Healthcare, Inc $MOH Shares Bought by Fiera Capital Corp
Fiera Capital Corp increased its stake in Molina Healthcare, Inc by 68.8% during the third quarter, acquiring an additional 98,431 shares. Several other institutional investors also adjusted their positions in the company, with institutional investors and hedge funds owning 98.50% of the stock. Analysts have a consensus "Hold" rating on Molina Healthcare with an average price target of $162.64, while the company recently missed quarterly earnings estimates.
Candel Therapeutics prices $100M public offering
Candel Therapeutics (NASDAQ:CADL) has priced a public offering of approximately 18.3 million shares at $5.45 each, aiming to raise $100 million in gross proceeds. The funds will support commercialization activities for aglatimagene besadenovec (CAN-2409) in prostate cancer and ongoing development for its Phase 3 trial in non-small cell lung cancer. Citigroup, Cantor, and Stifel are joint bookrunning managers for the offering.
Centene CEO: My stressful schedule ‘wasn’t actually making me better at my job’—how she avoids burnout today
Centene CEO Sarah London, who became the youngest woman to lead a Fortune 500 company in 2022, candidly shares her experience with burnout and how she overcame it. Initially sacrificing her well-being for work, she realized her intense schedule wasn't improving her job performance. London now prioritizes exercise, adequate sleep, and reading fiction, emphasizing the importance of disciplined self-care for high achievers.
Centene Corporation $CNC Shares Purchased by Alberta Investment Management Corp
Alberta Investment Management Corp increased its holdings in Centene Corporation (NYSE:CNC) by 22.1% in the third quarter, making it their 29th largest holding. Other institutional investors also adjusted their stakes in Centene, with institutional ownership standing at 93.63%. Centene recently reported earnings that beat analyst expectations and has received various "hold" ratings from analysts, with a consensus target price of $41.88.
Centene Stock Just Shocked Wall Street – Here’s What You Need to Know
Centene (CNC) has released new earnings and guidance that impact its position in the US health insurance market, particularly regarding Medicaid, Medicare, and ACA plans. The company is actively streamlining its portfolio and improving profit margins, which has significant implications for both consumers' healthcare costs and investors' portfolios. Experts highlight Centene as a core player highly sensitive to political shifts and medical cost trends, making it a "macro story stock" that requires active monitoring.
Centene Stock Just Shocked Wall Street – Here’s What You Need to Know
Centene Corp. (CNC) has released new earnings and guidance that impact the health insurance market, especially for Medicaid and ACA plans. The company is focusing on improving profit margins, stabilizing membership amid Medicaid redeterminations, and cleaning up its portfolio by exiting lower-margin businesses. This strategy could lead to tighter networks and increased digital tools for consumers, while investors are watching for consistent earnings growth and the company's ability to manage medical costs and policy shifts.
Deutsche Bank Raises Centene (CNC) PT to $39 While Maintaining Hold Rating
Deutsche Bank has increased its price target for Centene (CNC) to $39, up from $32, while retaining a Hold rating. This adjustment follows Centene's Q4 2025 earnings report, where the company reported a diluted loss of $1.19 per share, but full-year adjusted EPS slightly exceeded expectations. Centene also provided 2026 revenue guidance of $170 to $174 billion and anticipates strong adjusted EPS growth, driven by expected margin recovery in the ACA marketplace and progress towards breakeven in Medicare Advantage.
Deutsche Bank Raises Centene (CNC) PT to $39 While Maintaining Hold Rating
Deutsche Bank has increased its price target for Centene (NYSE: CNC) to $39 from $32, while reiterating a Hold rating, noting the stock was previously affected by downward industry trends. This follows Centene's Q4 2025 earnings report, which showed diluted loss of $1.19 per share but full-year adjusted EPS slightly exceeding expectations. The company provided a 2026 revenue guidance of $170 to $174 billion and anticipates adjusted EPS growth over 40%, with management expecting meaningful margin recovery in the ACA marketplace despite projected Medicaid membership decline.
Centene Pulls 2025 Guidance as Marketplace Growth Falters
Centene has withdrawn its 2025 financial guidance due to slowing growth in the Affordable Care Act marketplace. The company noted that the strong growth experienced post-COVID-19 is subsiding, impacting future revenue and membership projections. This decision reflects a broader trend of normalization in the health insurance sector after a period of significant expansion.
Vitality 2023: Americans are optimistic despite facing physical, mental, and financial health challenges
A new study by The Cigna Group, "Vitality in America," reveals that while American adults continue to struggle with physical, emotional, and financial health, their optimism has increased year over year. The study, based on a survey of 10,000 adults, shows a stable overall vitality score of 67.2 out of 100, with 47% of adults looking forward to each day. It highlights that individuals with healthy habits and strong mental health exhibit higher vitality, and that high vitality workers perform better and are more satisfied with their jobs.
Coronation Fund Managers Ltd. Sells 9,872 Shares of Elevance Health, Inc. $ELV
Coronation Fund Managers Ltd. has reduced its stake in Elevance Health (NYSE:ELV) by 7.2%, selling 9,872 shares to hold 127,495 shares valued at $41.2 million. This position represents 2.1% of Coronation's portfolio. The article also notes mixed analyst sentiments, with Zacks lowering some near-term EPS estimates while raising a Q4 2027 forecast, and MarketBeat's consensus being a "Moderate Buy" with an average target price of $390.55.
Centene (NYSE:CNC) Lowered to Hold Rating by Wall Street Zen
Centene (NYSE:CNC) has been downgraded by Wall Street Zen from a "buy" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $41.81. Despite topping quarterly revenue estimates with $49.73 billion and exceeding EPS expectations, the company reported a negative net margin and issued FY2026 guidance of $3.00 EPS. Institutional ownership is high at 93.63%, with major investors continuing to build positions.
Centene (NYSE:CNC) Given New $37.00 Price Target at Jefferies Financial Group
Jefferies Financial Group has set a new price target of $37.00 for Centene (NYSE:CNC), down from $43.00, while maintaining a "hold" rating. The new target implies an 8.70% potential downside from the current stock price. Centene recently reported earnings of ($1.19) EPS on revenue of $49.73 billion, beating analyst expectations.
Raymond James Financial Cuts Humana (NYSE:HUM) Price Target to $230.00
Raymond James Financial has lowered its price target for Humana (NYSE:HUM) to $230.00 from $340.00, while maintaining an "outperform" rating, suggesting a potential 25.05% upside. This adjustment comes amidst broader analyst caution driven by concerns over Medicare Advantage cost pressures, lower quality ratings, and a conservative FY2026 outlook from the company, despite reporting Q4 EPS slightly above estimates. The average analyst rating for Humana is currently "Hold" with an average target price of $238.29.
Thrivent Financial for Lutherans Cuts Position in Centene Corporation $CNC
Thrivent Financial for Lutherans significantly reduced its stake in Centene Corporation (NYSE:CNC) by 98.1% in the third quarter, selling over 1.7 million shares. Despite this, other institutional investors have either increased their holdings or initiated new positions in Centene. The company recently beat quarterly earnings estimates but issued lower-than-expected full-year 2026 EPS guidance, leading to a "Hold" average analyst rating with a $41.50 price target.
Caprock Group LLC Acquires New Position in Elevance Health, Inc. $ELV
Caprock Group LLC has acquired a new position in Elevance Health, Inc. (NYSE:ELV), purchasing 5,140 shares valued at approximately $1.64 million, as institutional investors now hold around 89.24% of the stock. Elevance Health reported better-than-expected Q3 earnings per share of $3.33, though revenue slightly missed consensus, and the company increased its quarterly dividend. Analysts maintain a "Moderate Buy" consensus rating with an average target price of $390.55, despite some recent downgrades and target price trims.
AG Paxton seeks information for BCBS; Conduent data breach
Texas Attorney General Ken Paxton has launched an investigation into a major data breach affecting Blue Cross Blue Shield of Texas (BCBS) and Conduent Business Services, LLC. The breach, which Conduent described as a "cyber incident" that occurred last year, potentially exposed the personal and health insurance information of approximately four million Texans, including Medicaid recipients. Paxton's office has issued Civil Investigative Demands to both companies, seeking documents and information to determine compliance with state laws and to prevent future breaches.
NWS Stock Price, Forecast & Analysis | NEWS CORP - CLASS B (NASDAQ:NWS)
The article provides a detailed analysis of NEWS CORP - CLASS B (NASDAQ:NWS) stock, covering its current price, performance, and forecasts. It highlights a ChartMill Fundamental rating of 6/10, strong profitability, and good financial health. Analysts project a potential 61.35% price increase, with an average target of $41.95, and anticipate EPS growth of 8.08% and revenue growth of 1.55% for the next year.
Seahawks legend helps WA students make sure no one eats alone at school
Coordinated Care, a Centene Corporation subsidiary, partnered with Seattle Seahawks legend Walter Jones to celebrate "No One Eats Alone Day" in 35 Washington schools and 5,000 schools nationwide. The initiative aims to combat social isolation among students by providing "Belonging Boxes" with lesson plans, activities, and conversation starters to foster connection and improve mental health. This effort is part of a broader community-impact strategy by Centene, highlighting its commitment to youth well-being.
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know
Several healthcare and medical technology stocks including Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene saw significant jumps after a softer-than-expected January Consumer Price Index (CPI) report. The favorable inflation data led to increased market expectations for Federal Reserve interest rate cuts, benefiting stock valuations. Astrana Health, specifically, experienced a 3.8% rise, though its shares have been highly volatile and are down 25.5% year-to-date.
Oppenheimer Asset Management Inc. Trims Stake in Elevance Health, Inc. $ELV
Oppenheimer Asset Management Inc. significantly reduced its stake in Elevance Health, Inc. ($ELV) by 62.2% in the third quarter, selling 10,300 shares and retaining 6,247 shares valued at approximately $2.02 million. This comes as Elevance Health reported strong Q3 earnings, beating EPS expectations and showing 9.6% revenue growth, leading them to raise their quarterly dividend and set FY2026 EPS guidance. Despite mixed analyst ratings, the stock holds a "Moderate Buy" consensus target price of $390.55, with institutional investors owning a substantial 89.24% of the company.
Ambetter Health Celebrates Completion of New Playground at Southeast Park
Ambetter Health, in collaboration with KABOOM! and the City of Hialeah, has completed a new kid-designed playground at Southeast Park. Over 100 volunteers built the playspace in a single day on January 30, providing a vibrant area for children's play and recreation. This project marks the second partnership between the organizations, aiming to promote healthier and active lifestyles for the community's youth.
Wealthfront Advisers LLC Reduces Stake in Molina Healthcare, Inc $MOH
Wealthfront Advisers LLC decreased its holdings in Molina Healthcare, Inc. by 20.2% in the third quarter of 2025, selling 9,687 shares and retaining 38,368 shares valued at approximately $7.34 million. This reduction comes as Molina Healthcare reported a significant quarterly EPS miss of ($2.75) against an expected $0.43, despite revenue exceeding estimates. The stock currently has a consensus "Hold" rating from analysts with an average price target of $164.79, trading substantially below its 12-month high.
Madison Asset Management LLC Decreases Holdings in Elevance Health, Inc. $ELV
Madison Asset Management LLC significantly reduced its stake in Elevance Health, Inc. (NYSE:ELV) by 88.4% in the third quarter, selling 126,753 shares and retaining 16,600 shares valued at $5.36 million. Despite this, other institutional investors have made smaller adjustments to their positions, and 89.24% of the stock is held by hedge funds and institutional investors. The article also provides an overview of recent analyst ratings, stock performance metrics, dividend information, and key news impacting Elevance Health, including some upward revisions to future EPS estimates by Zacks but also notable cuts to near-term forecasts and a House Judiciary probe investigation.
FMR LLC's Strategic Acquisition of Centessa Pharmaceuticals Shares
FMR LLC significantly increased its stake in Centessa Pharmaceuticals PLC by acquiring an additional 2,617,696 shares at $25.01 per share on December 31, 2025. This strategic move aligns with FMR LLC's focus on innovative, high-growth potential companies in the biotechnology sector. The acquisition brings FMR LLC's total holdings in Centessa Pharmaceuticals to 8,894,939 shares, demonstrating confidence in the clinical-stage pharmaceutical company despite its current operating losses.
20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative
Superior HealthPlan and The Centene Foundation are collaborating with 20 Texas schools to implement the No One Eats Alone (NOEA) program. This initiative, organized by Sandy Hook Promise, aims to tackle social isolation among students, particularly those in 5th through 8th grades. The program provides tools and activities to help students build self-esteem, improve social connections, and create more inclusive school environments.
More than 1 million students join 'No One Eats Alone' to fight school loneliness
Centene's partner, Superior HealthPlan, and the Centene Foundation are sponsoring the "No One Eats Alone" program in 20 Texas schools to combat student social isolation. More than a million students nationally, particularly in grades 5-8, are participating in the program, which uses peer-led lessons, art projects, and leadership units. The initiative, delivered by Sandy Hook Promise, aims to build self-esteem and social connections among students.
TD Cowen Issues Positive Forecast for Centene (NYSE:CNC) Stock Price
TD Cowen increased its price target for Centene (NYSE:CNC) stock from $34.00 to $38.00, maintaining a "hold" rating, though this still implies a potential downside from its current price. Several other analysts have also issued reports on Centene, with the company currently holding an average "Hold" rating and a consensus price target of $41.50. Centene recently reported quarterly earnings that beat consensus estimates and provided FY 2026 guidance, while institutional investors have been actively trading its shares.
20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative
Superior HealthPlan and The Centene Foundation are partnering with 20 Texas schools to implement the No One Eats Alone (NOEA) program, which aims to combat social isolation among 5th to 8th-grade students. This initiative, sponsored by The Centene Foundation and organized by Sandy Hook Promise, provides interactive lessons and peer leadership activities to foster inclusivity and help students connect with their peers. The program, which Superior HealthPlan has supported for a decade, addresses the risks of social isolation identified by the CDC for mental and physical health.
20 Texas Schools Partner with Superior HealthPlan and The Centene Foundation to Address Social Isolation with No One Eats Alone Initiative – Company Announcement - FT.com
Superior HealthPlan and The Centene Foundation are partnering with 20 Texas schools to implement the No One Eats Alone® (NOEA) program. This initiative, which has been in Texas schools for a decade, aims to combat social isolation among students, particularly those in 5th to 8th grades. The program uses interactive lessons and peer leadership to foster inclusivity and connection, with over 1 million students nationwide expected to participate.
Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC)
Guggenheim analyst Jason Cassorla has maintained a Buy rating on Tenet Healthcare (THC) with a price target of $257.00. This comes despite a recent downgrade from TipRanks – xAI to Hold. The company reported quarterly revenue of $5.29 billion and a net profit of $342 million for the quarter ending September 30, though corporate insider sentiment is reported as negative due to increased selling activity.
Elevance Health Q3 EPS Forecast Decreased by Zacks Research
Zacks Research has decreased its Q3 2026 EPS forecast for Elevance Health (NYSE:ELV) to $5.41 from $5.68, maintaining a "Hold" rating. Despite this, the company recently reported Q3 EPS of $3.33, beating estimates, and revenue of $49.31 billion, slightly missing expectations. Analysts have a "Moderate Buy" consensus rating with a target price of $390.55, and Elevance Health also increased its quarterly dividend to $1.72.
Humana Incurs Q4 Loss, Revenues Up Y/Y on CenterWell Unit Strength
Humana Inc. reported a narrower-than-expected adjusted loss of $3.96 per share in Q4 2025, with revenues rising 11.8% year-over-year to $32.6 billion, driven by the strong performance of its CenterWell segment. Despite revenue growth and premium gains, the company faced challenges from escalating operating expenses, a significant drop in investment income, and a decline in medical membership. For 2026, Humana anticipates robust revenue growth to at least $160 billion, but projects a substantial decline in adjusted EPS to at least $9.00.
Investment Management Associates Inc. ADV Makes New $20.24 Million Investment in Molina Healthcare, Inc $MOH
Investment Management Associates Inc. ADV has made a new $20.24 million investment in Molina Healthcare, Inc., acquiring 105,787 shares, which now represents 6.0% of the fund's portfolio and is its fifth-largest holding. Despite this significant investment, Molina Healthcare recently reported a substantial EPS miss for the quarter, though revenue exceeded expectations. The stock currently has a "Hold" consensus rating from analysts.
Investment Management Associates Inc. ADV Takes Position in Elevance Health, Inc. $ELV
Investment Management Associates Inc. ADV initiated a new position in Elevance Health, Inc. (NYSE:ELV) during Q3, acquiring 13,108 shares valued at approximately $4.235 million, representing 1.2% of their portfolio. Elevance Health surpassed Q3 earnings expectations with $3.33 EPS and reported strong revenue growth, leading to a "Moderate Buy" consensus rating and a target price of $390.55 from Wall Street analysts. The company also increased its quarterly dividend to $1.72 per share, offering an annualized yield of around 2.1%.
Humana stock hits 52-week low at $185.98
Humana Inc. stock reached a 52-week low of $185.98, reflecting a significant -27.98% decline over the past year due to broader industry pressures and company-specific hurdles. Despite challenges, the company maintains a 1.87% dividend yield and has sustained dividend payments for 15 consecutive years. Investors are closely watching its upcoming Q4 2025 earnings report and navigating mixed analyst ratings, with some viewing it as undervalued while others express concerns over policy risks and Medicare Advantage payment rate changes.
CMS to crack down on ACA plan marketing, tighten income verifications
CMS has proposed new 2027 benefit and payment parameters for ACA health insurance marketplaces, aiming to curb healthcare fraud, misleading marketing, and tighten income verification rules. The proposed rule would prohibit practices like offering cash incentives and using AI-generated endorsements, and expand income verification for low-income consumers while aligning with the One Big Beautiful Bill Act. It also introduces changes to plan design, allowing for easier enrollment in catastrophic plans and giving issuers more flexibility.
Healthcare Triangle, Inc. Signs Definitive Agreement with Teyame AI LLC | Kodiak Solutions Acquires BESLER
Healthcare Triangle, Inc. (HCTI) announced a definitive agreement to acquire Teyame AI LLC, expected to generate an additional $38M in revenue and $5M in EBITDA, expanding HCTI's SaaS footprint in Europe and Latin America. Separately, Kodiak Solutions acquired Besler & Company, LLC (BESLER) to enhance its revenue integrity and reimbursement services for healthcare providers. These strategic moves aim to boost financial performance and broaden service offerings in the healthcare IT sector.
Candriam S.C.A. Trims Stake in Elevance Health, Inc. $ELV
Candriam S.C.A. reduced its stake in Elevance Health (NYSE:ELV) by 27% in Q3 2025, selling 18,211 shares, though its remaining 49,258 shares are valued at $15.9 million. Elevance Health reported strong Q3 earnings, beating analyst EPS estimates, and increased its quarterly dividend. The company maintains a "Moderate Buy" consensus rating from analysts.
Morgan Stanley Maintains a Hold on Centene Corporation (CNC)
Morgan Stanley has maintained a "Hold" rating for Centene Corporation (CNC), setting a price target of $38.00. This comes after Centene announced its 2025 results, reporting a GAAP diluted loss per share of $13.53 and an adjusted diluted EPS of $2.08, but projecting adjusted diluted EPS greater than $3.00 for 2026. The company is working towards restoring its embedded earnings power as a healthcare enterprise offering government-sponsored programs.
Morgan Stanley Maintains a Hold on Centene Corporation (CNC)
Morgan Stanley reaffirmed a "Hold" rating on Centene Corporation (NYSE:CNC) with a price target of $38.00, following the company's announcement of its 2025 results and 2026 guidance. Centene reported a 2025 GAAP diluted loss per share of $13.53 but adjusted diluted EPS of $2.08, and expects 2026 adjusted diluted EPS to exceed $3.00, indicating progress in restoring earnings power. Despite acknowledging Centene's growth potential, the article suggests other AI stocks hold greater promise for higher returns and lower risk.
Republican-led US House panel issues subpoenas to eight health insurers, Axios reports
A Republican-led US House panel has issued subpoenas to eight Affordable Care Act health insurers as part of an expanding investigation into potential fraud concerning the use of premium subsidies, Axios reported. The subpoenas, issued by House Judiciary Chair Jim Jordan, demand documents related to subsidized ACA enrollees and discussions on subsidy-related fraud, with a deadline of February 23. This action follows previous requests in December triggered by federal auditors detecting subsidized coverage for non-existent individuals and other fraud risks.
SVB Wealth LLC Sells 4,116 Shares of Elevance Health, Inc. $ELV
SVB Wealth LLC reduced its stake in Elevance Health, Inc. by 19.7% in the third quarter, selling 4,116 shares and leaving them with 16,749 shares valued at $5.41 million. Despite this, other institutional investors increased their holdings in ELV. Elevance Health (NYSE:ELV) reported strong quarterly earnings, beating EPS estimates, and raised its quarterly dividend, while analysts maintain a "Moderate Buy" consensus with an average price target of $390.55.
Analysts Are Bullish on Top Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Centene (CNC)
This article highlights bullish sentiments from analysts on two healthcare stocks: Hinge Health, Inc. Class A (HNGE) and Centene (CNC). Barclays analyst Saket Kalia maintained a Buy rating on Hinge Health with a $60.00 price target, while analyst Andrew Mok CFA also maintained a Buy rating on Centene with a $54.00 price target. The article provides current analyst consensus ratings and average price targets for both companies, indicating significant upside potential for Hinge Health.
Humana (HUM) Q4 Earnings: What To Expect
Humana (NYSE:HUM) is preparing to release its Q4 earnings this Wednesday, with analysts expecting a revenue growth of 9.8% year-on-year to $32.06 billion and an adjusted loss of -$3.99 per share. The company has historically surpassed revenue estimates and added 150,000 customers last quarter. Despite a generally underperforming health insurance providers segment, Humana's stock is trading significantly below its average analyst price target.
Centene Says Behavioral Health Accounts for Half of Excess Costs
Centene Corp. reported that behavioral health utilization, especially applied behavioral analysis (ABA) therapy, accounted for roughly 50% of its excess costs in Q4 2025, with home health and high-cost drugs being secondary drivers. The company formed an ABA task force to analyze data and address concerns about high-volume, potentially outcomes-lacking ABA therapy, implementing a new member engagement program led by doctorate-level BCBAs. Centene aims for Medicaid segment profitability by optimizing networks, implementing new clinical programs, and focusing on fraud reduction.
